Analyst Reporting

Analyst Reports


The information and content contained on this webpage is intended to be used or viewed solely in jurisdictions where it is lawful to do so. If you access the broker research reports contained herein (Analyst Reports), you must inform yourself about, and comply with, applicable laws and regulations, including (without limitation) observing securities laws and regulations in jurisdictions that impose restrictions on the distribution of such Analyst

Rhythm Biosciences Limited, its directors, officers, employees, associates, affiliates and agents disclaim all liability and responsibility for any direct or indirect loss, or damage, which may be incurred by any recipient through any information, omission, error, or inaccuracy contained in the Analyst Reports.

All information, opinions, conclusions, estimates or recommendations provided in the Analyst Reports have been prepared by third parties and Rhythm Biosciences Limited, its directors, officers, employees, associates, affiliates and agents make no representation or warranty as to the accuracy, completeness, or reliability of information prepared by third parties, including any price target, earnings forecast or other statements (including forward-
looking statements) about Rhythm Biosciences Limited’s business activities.

By proceeding, you agree that you are a sophisticated investor or that you will seek professional financial advice before buying or selling any securities referred in the Analyst Reports contained herein.

By proceeding to access the Analyst Reports you are confirming and agreeing that your access does not violate applicable laws, including the laws of your home jurisdiction and you have read, understood and accept the disclaimer as outlined above.
27 October 2023 - MST Access 'Screening Markets Expanding' Cover Page
27 October 2023 - MST Access 'Screening Markets Expanding'
MST-Access-RHY-Update-Report-29Nov22 Cover Page
29 November 2022 - MST Access "Update"
MST-Access-RHY-Update-Report-5Jul22_ Cover Page
5 July 2022 - MST Access "Approval to Unblock an Expanded Market"
MST-Access-RHY-Update-21Apr22 Cover Page
21 April 2022 - MST Access " Update - Study 7 Opens Market Opportunities"
Rhythm-Biosciences-research-update-13-04-2022 Cover Page
12 April 2022 - Pitt Street Reserach "Update - Study 7 is Another Success"
RHY-update-7-Dec-2021 Cover Page
7 December 2021 - Pitt Street Research "Ticket booked to Europe"
MST-Access-RHY-Update-12Nov21 Cover Page
12 November 2021 - MST Access " Market Entries in Sight"
MST-Access-RHY-Initiation-Report-17Jun21 Cover Page
17 June 2021 - MST Access "Breakthrough Bowel Cancer Diagnostic"
Rhythm-Biosciences-initiation-report-18-May-2021 Cover Page
18 May 2021 - Pitt Street Research " Bowel Cancer Screening Made Simple"

About us:



Rhythm Biosciences

Bio21 Institute
30 Flemington Road
Parkville VIC 3010

Keep up to date:

Please provide your full name
You must provide an email address

Connect with us: